Exploring the Efficacy of Benralizumab in Chronic Eosinophilic Pneumonia Following Corticosteroid Therapeutic Failure: A Case Report
Abstract
Chronic eosinophilic pneumonia is a rare idiopathic disease characterized by eosinophilic infiltrates in the alveoli and interstitial lung spaces. There are no specific diagnostic tests for this condition, but it is suspected in patients presenting with dyspnea, cough, a tomographic pattern of consolidations, peripheral ground-glass opacities, and peripheral eosinophilia. This report presents the case of a male patient with chronic eosinophilic pneumonia that was unresponsive to corticosteroid treatment.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.